Tumor microenvironment-activated hollow vanadium-based nanoplatform for precise therapy of lung cancer through synergistically reversing cisplatin resistance

被引:4
作者
Ran, Lang [1 ]
Xiao, Jianmin [1 ]
Zhang, Weijie [1 ]
Wang, Miaomiao [1 ]
Xin, Huan [1 ]
Li, Huimin [1 ]
Hao, Hong [1 ]
Wang, Maoyang [1 ]
Wang, Xiaofei [1 ]
Tian, Geng [1 ]
Zhang, Guilong [1 ]
机构
[1] Binzhou Med Univ, Shandong Technol Innovat Ctr Mol Targeting & Intel, Sch Pharm, Yantai 264003, Peoples R China
基金
中国国家自然科学基金;
关键词
Cisplatin resistance; Vanadium -based Nanoplatform; Glutamyl cysteine ligase; Excision repair cross -complementing 1; Lung cancer; IN-VITRO; PRODRUG; NANOPARTICLES; CHEMOTHERAPY; MECHANISMS; DELIVERY;
D O I
10.1016/j.cej.2024.149448
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The resistance and side effect of cisplatin (CDDP) were still great challenges for highly efficient therapy of lung cancer in clinic. The studies indicated that the CDDP resistance mainly involved GSH-mediated inactivation and the damaged DNA repair. Herein, a novel vanadium-based nanoplatform was designed via platelet-derived growth factor receptor-beta (PDGFR-beta)-recognizing cyclic peptide (PDGFB)-labeled liposomes coating onto the hollow vanadium-doped mesoporous silica nanoparticle (HVMSN) loaded Pt (IV) prodrugs (pLi-HVMSN-Pt). This nanoplatform actively targeted tumor tissue, and then effectively responded to weakly acidic and high GSH of tumor microenvironment, making Pt (IV) prodrugs and vanadium ions be precisely delivered and intelligently released. Moreover, the vanadium ions significantly downregulated the expression of glutamyl cysteine ligase (GCL) and excision repair cross-complementing 1 (ERCC1), which inhibited the synthesis of GSH in cells and the damaged DNA repair. These synergistic actions dramatically increased the sensitivity of tumor cells to Pt-based drug, and then reversed CDDP resistance. Furthermore, in vivo experiment results demonstrated highly efficient suppression of tumor growth induced by the pLi-HVMSN-Pt. Therefore, this work provided a novel strategy for reversing CDDP-resistance and the precise therapy of lung cancer.
引用
收藏
页数:11
相关论文
共 55 条
[11]  
Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351
[12]   Systems biology of cisplatin resistance: past, present and future [J].
Galluzzi, L. ;
Vitale, I. ;
Michels, J. ;
Brenner, C. ;
Szabadkai, G. ;
Harel-Bellan, A. ;
Castedo, M. ;
Kroemer, G. .
CELL DEATH & DISEASE, 2014, 5 :e1257-e1257
[13]   Molecular mechanisms of cisplatin resistance [J].
Galluzzi, L. ;
Senovilla, L. ;
Vitale, I. ;
Michels, J. ;
Martins, I. ;
Kepp, O. ;
Castedo, M. ;
Kroemer, G. .
ONCOGENE, 2012, 31 (15) :1869-1883
[14]   Cisplatin-Induced Ototoxicity: Updates on Molecular Targets [J].
Gentilin, Erica ;
Simoni, Edi ;
Candito, Mariarita ;
Cazzador, Diego ;
Astolfi, Laura .
TRENDS IN MOLECULAR MEDICINE, 2019, 25 (12) :1123-1132
[15]   Role of transporters in the distribution of platinum-based drugs [J].
Harrach, Saliha ;
Ciarimboli, Giuliano .
FRONTIERS IN PHARMACOLOGY, 2015, 6
[16]   HXV2O5 Nanocatalysts Combined with Ultrasound for Triple Amplification of Oxidative Stress to Enhance Cancer Catalytic Therapy [J].
Hou, Linqian ;
Gong, Fei ;
Han, Zhihui ;
Wang, Yuanjie ;
Yang, Yuqi ;
Cheng, Shuning ;
Yang, Nailin ;
Liu, Zhuang ;
Cheng, Liang .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 61 (39)
[17]   Vanadyl nanocomplexes enhance photothermia-induced cancer immunotherapy to inhibit tumor metastasis and recurrence [J].
Hu, Doudou ;
Xu, Hongxia ;
Zhang, Wei ;
Xu, Xiaodan ;
Xiao, Bing ;
Shi, Xueying ;
Zhou, Zhuxian ;
Slater, Nigel K. H. ;
Shen, Youqing ;
Tang, Jianbin .
BIOMATERIALS, 2021, 277 (277)
[18]   Comparative dynamics of microglial and glioma cell motility at the infiltrative margin of brain tumours [J].
Juliano, Joseph ;
Gil, Orlando ;
Hawkins-Daarud, Andrea ;
Noticewala, Sonal ;
Rockne, Russell C. ;
Gallaher, Jill ;
Massey, Susan Christine ;
Sims, Peter A. ;
Anderson, Alexander R. A. ;
Swanson, Kristin R. ;
Canoll, Peter .
JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2018, 15 (139)
[19]   Genetic analyses in mouse fibroblast and melanoma cells demonstrate novel roles for PDGF-AB ligand and PDGF receptor alpha [J].
Kadrmas, Julie L. ;
Beckerle, Mary C. ;
Yoshigi, Masaaki .
SCIENTIFIC REPORTS, 2020, 10 (01)
[20]   Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug [J].
Lee, Keefe Guang Zhi ;
Babak, Maria V. ;
Weiss, Andrea ;
Dyson, Paul J. ;
Nowak-Sliwinska, Patrycja ;
Montagner, Diego ;
Ang, Wee Han .
CHEMMEDCHEM, 2018, 13 (12) :1210-1217